English  |  正體中文  |  简体中文  |  Total items :2854037  
Visitors :  45329035    Online Users :  713
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to a point in the index:
Or type in a year:
Show Most Recent First Ordering With Oldest First

Showing items 2234171-2234220 of 2346973  (46940 Page(s) Totally)
<< < 44679 44680 44681 44682 44683 44684 44685 44686 44687 44688 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-01T01:54:16Z Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma Omata M.; Lesmana L.A.; Tateishi R.; Chen P.-J.; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; ANN-LII CHENG; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K.
臺大學術典藏 2021-09-01T01:54:17Z Molecular targeted therapy for advanced hepatocellular carcinoma: Current status and future perspectives Shen Y.-C.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:17Z Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions Shao Y.-Y.; Hu F.-C.; Liang J.-T.; Chiu W.-T.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏 2021-09-01T01:54:17Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:18Z Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy Lin C.-H.; Lien H.-C.; Hu F.-C.; Lu Y.-S.; Kuo S.-H.; Wu L.-C.; You S.-L.; ANN-LII CHENG; Chang K.-J.; Huang C.-S.
臺大學術典藏 2021-09-01T01:54:18Z Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway Chou C.H.; Chen P.-J.; Jeng Y.-M.; ANN-LII CHENG; Huang L.-R.; Cheng J.C.-H.
臺大學術典藏 2021-09-01T01:54:18Z Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG; Whang-Peng J.; Chen L.-T.
臺大學術典藏 2021-09-01T01:54:18Z Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design Hsu C.; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:19Z Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:19Z Sorafenib for the treatment of hepatocellular carcinoma across geographic regions Hsu C.; Shen Y.-C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:19Z Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:19Z Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast - A review of 42 primary and secondary cases in Taiwanese patients Lin Y.-C.; Tsai C.-H.; Wu J.-S.; Huang C.-S.; Kuo S.-H.; Lin C.-W.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:20Z Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study Faivre S.; Raymond E.; Boucher E.; Douillard J.; Lim H.Y.; Kim J.S.; Zappa M.; Lanzalone S.; Lin X.; DePrimo S.; Harmon C.; Ruiz-Garcia A.; Lechuga M.J.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:20Z Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma Yang S.-H.; Lin Z.-Z.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:20Z Lamivudine and hepatitis B reactivation Hsu C.; ANN-LII CHENG; Chen P.-J.
臺大學術典藏 2021-09-01T01:54:21Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; ANN-LII CHENG; Yang P.-C.
臺大學術典藏 2021-09-01T01:54:21Z Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients Chen C.-H.; Hu F.-C.; Huang G.-T.; Lee P.-H.; Tsang Y.-M.; ANN-LII CHENG; Chen D.-S.; Wang J.-D.; Sheu J.-C.
臺大學術典藏 2021-09-01T01:54:21Z Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:22Z Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment Shao Y.-Y.; Lin Z.-Z.; Liang P.-C.; Tien Y.-W.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:22Z Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:23Z The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma Lin Z.-Z.; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Hsu C.; Hu F.-C.; Jeng Y.-M.; Chung Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:23Z Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:23Z Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical application Lee J.-H.; ANN-LII CHENG; Lin C.-W.; Kuo S.-H.
臺大學術典藏 2021-09-01T01:54:24Z Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy Hsu C.; Wei S.-C.; ANN-LII CHENG; Chen P.-J.
臺大學術典藏 2021-09-01T01:54:24Z National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital Lin C.-C.; Yang C.-H.; ANN-LII CHENG; Chan W.-K.; Ho N.-N.
臺大學術典藏 2021-09-01T01:54:24Z Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial ANN-LII CHENG; Kang Y.-K.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Luo R.; Feng J.; Ye S.; Yang T.-S.; Xu J.; Sun Y.; Liang H.; Liu J.; Wang J.; Tak W.Y.; Pan H.; Burock K.; Zou J.; Voliotis D.; Guan Z.
臺大學術典藏 2021-09-01T01:54:25Z Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy Lin Y.-C.; Wei L.-H.; Shun C.-T.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-09-01T01:54:25Z Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway Dai H.-Y.; Hong C.-C.; Liang S.-C.; Yan M.-D.; Lai G.-M.; ANN-LII CHENG; Chuang S.-E.
臺大學術典藏 2021-09-01T01:54:25Z Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells Lin H.-J.L.; Zuo T.; Lin C.-H.; Chieh T.K.; Liyanarachchi S.; Sun S.; Shen R.; Deatherage D.E.; Potter D.; Asamoto L.; Lin S.; Yan P.S.; ANN-LII CHENG; Ostrowski M.C.; Huang T.H.-M.
臺大學術典藏 2021-09-01T01:54:26Z Comprehensive Locoregional Treatment and Systemic Therapy for Postmastectomy Isolated Locoregional Recurrence Kuo S.-H.; Huang C.-S.; Kuo W.-H.; ANN-LII CHENG; Chang K.-J.; Chia-Hsien Cheng J.
臺大學術典藏 2021-09-01T01:54:26Z OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma Gao M.; Yeh P.Y.; Lu Y.-S.; Hsu C.-H.; Chen K.-F.; Lee W.-C.; Feng W.-C.; Chen C.-S.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:26Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu C.; Kuo S.-H.; Hu F.-C.; ANN-LII CHENG; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2021-09-01T01:54:27Z Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma Kuo S.-H.; Yeh P.-Y.; Chen L.-T.; Wu M.-S.; Lin C.-W.; Yeh K.-H.; Tzeng Y.-S.; Chen J.-Y.; Hsu P.-N.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:27Z NF-κB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells Gao M.; Yeh P.Y.; Lu Y.-S.; Chang W.C.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:27Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Lin C.-C.; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏 2021-09-01T01:54:28Z Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia Hong C.-C.; Lay J.-D.; Huang J.-S.; ANN-LII CHENG; Tang J.-L.; Lin M.-T.; Lai G.-M.; Chuang S.-E.
臺大學術典藏 2021-09-01T01:54:28Z Sorafenib benefits Asian patients with advanced HCC ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:28Z Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells Chen K.-F.; Yeh P.-Y.; Yeh K.-H.; Lu Y.-S.; Huang S.-Y.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:28Z Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; ANN-LII CHENG; Pao W.; Yang P.-C.
臺大學術典藏 2021-09-01T01:54:29Z Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; ANN-LII CHENG; Yang P.-C.; Yang C.-H.
臺大學術典藏 2021-09-01T01:54:29Z Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation Huang T.-C.; Yeh K.-H.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-09-01T01:54:29Z FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C δ signaling Hung J.-H.; Lu Y.-S.; Wang Y.-C.; Ma Y.-H.; Wang D.-S.; Kulp S.K.; Muthusamy N.; Byrd J.C.; ANN-LII CHENG; Chen C.-S.
臺大學術典藏 2021-09-01T01:54:30Z Differential expression of glucocorticoid receptor in carcinomas of the human digestive system Lien H.-C.; Lu Y.-S.; Shun C.-T.; Yao Y.-T.; Chang W.-C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:30Z Long-term follow-up of gastrectomized patients with mucosa-associated lymphoid tissue lymphoma: Need for a revisit of surgical treatment Kuo S.-H.; Chen L.-T.; Wu M.-S.; Lin C.-W.; Yeh K.-H.; Kuo K.-T.; Yeh P.-Y.; Tzeng Y.-S.; Wang H.-P.; Hsu P.-N.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:30Z A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial Hsu C.; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; ANN-LII CHENG; Chen P.-J.
臺大學術典藏 2021-09-01T01:54:30Z Prognostic factors in extrapulmonary small cell carcinomas: A large retrospective study Lin Y.-L.; Chung C.-Y.; Chang C.-S.; Wu J.-S.; Kuo K.-T.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:31Z Organization-based performance measures of cancer care quality: Core measure development for breast cancer in Taiwan Chung K.-P.; Lai M.-S.; Cheng S.H.; Tang S.-T.; Huang C.C.; ANN-LII CHENG; Hsieh P.-C.
臺大學術典藏 2021-09-01T01:54:31Z Molecular targeted therapy for advanced hepatocellular carcinoma Shen Y.C.; Hsu C.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:31Z Epidemiology of multiple myeloma in Taiwan: Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years Huang S.-Y.; Yao M.; Tang J.-L.; Lee W.-C.; Tsay W.; ANN-LII CHENG; Wang C.-H.; Chen Y.-C.; Shen M.-C.; Tien H.-F.
臺大學術典藏 2021-09-01T01:54:32Z Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; ANN-LII CHENG; Hsu C.-H.

Showing items 2234171-2234220 of 2346973  (46940 Page(s) Totally)
<< < 44679 44680 44681 44682 44683 44684 44685 44686 44687 44688 > >>
View [10|25|50] records per page